Trinity Biotech ADR buy StockNews.com
Start price
26.12.23
/
50%
€0.40
Target price
26.12.24
-
Performance (%)
4.04%
Price
22.02.24
€0.41
Summary
This prediction is currently active. With a performance of 4.04%, the BUY prediction by StockNews_com for Trinity Biotech ADR is trending in the right direction. This prediction currently runs until 26.12.24. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Trinity Biotech ADR | - | - |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by StockNews_com for this prediction
In the thread Trinity Biotech ADR diskutieren
Trinity Biotech plc (NASDAQ: TRIB) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for TRIB provided by MarketBeat